STX2 and hemolytic-uremic syndrome: The overall frequency of reactive plasma with at least one subunit of Stx2 in NHC group (67%) was significantly lower than the frequency in HUS (86%) and HUSrec (82%) clinical groups (Fig. 2B) when compared by the Chi square test (p<0.05).